Viking Therapeutics (VKTX) News Today $31.11 -0.18 (-0.58%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$31.14 +0.03 (+0.10%) As of 07/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VKTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Concurrent Investment Advisors LLC Buys New Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 13 at 3:38 AM | marketbeat.comPrincipal Financial Group Inc. Sells 30,629 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)July 13 at 3:20 AM | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Purchased by Caas Capital Management LPJuly 11 at 8:12 AM | marketbeat.comBanque Pictet & Cie SA Takes Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)July 11 at 5:39 AM | marketbeat.comU.S. Capital Wealth Advisors LLC Sells 8,423 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)July 10 at 5:26 AM | marketbeat.comViking Therapeutics (VKTX) Soars 9.7% on Looming Weight Loss Drug Trial ResultsJuly 9, 2025 | insidermonkey.comFinancial Counselors Inc. Acquires 16,823 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)July 9, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 8.1% - Still a Buy?July 8, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Bought by Cambridge Investment Research Advisors Inc.July 8, 2025 | marketbeat.comBetter Growth Buy: Eli Lilly vs. Viking TherapeuticsJuly 7, 2025 | fool.comAugust 22nd Options Now Available For Viking Therapeutics (VKTX)July 5, 2025 | nasdaq.comInsider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) CFO Sells 4,266 Shares of StockJuly 4, 2025 | insidertrades.comWhy I Think Viking Therapeutics Is an Asymmetric Growth OpportunityJuly 4, 2025 | fool.comInsider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) CFO Sells 4,266 Shares of StockJuly 3, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) COO Sells $118,466.82 in StockJuly 3, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) CEO Sells 26,889 SharesJuly 3, 2025 | marketbeat.comVKTX - Viking Therapeutics Inc Sustainability - MorningstarJuly 3, 2025 | morningstar.comMH.C. Wainwright Keeps Their Buy Rating on Viking Therapeutics (VKTX)July 2, 2025 | theglobeandmail.comViking Therapeutics (NASDAQ:VKTX) Shares Up 7.7% - Here's What HappenedJuly 2, 2025 | marketbeat.comGot $200? 2 Biotech Stocks to Buy and Hold ForeverJuly 1, 2025 | fool.comViking Therapeutics, Inc. (NASDAQ:VKTX) Given Consensus Rating of "Buy" by BrokeragesJuly 1, 2025 | marketbeat.com3 Biotech Stocks to Watch: Iovance, Neurocrine & VikingTiming matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value...June 29, 2025 | marketbeat.comWhy This Weight Loss Drug Company's Stock Surged TodayJune 26, 2025 | fool.comVKTX Viking Therapeutics, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comViking Therapeutics, Inc. (NASDAQ:VKTX) Stock Holdings Increased by International Assets Investment Management LLCJune 26, 2025 | marketbeat.comOppenheimer & Co. Inc. Acquires 23,481 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)June 26, 2025 | marketbeat.comWhy Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In ObesityJune 25, 2025 | msn.comViking Therapeutics (NASDAQ:VKTX) Receives "Buy" Rating from HC WainwrightJune 25, 2025 | marketbeat.comViking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735June 25, 2025 | prnewswire.comMy 5 Favorite Dirt Cheap Stocks to Buy Right NowJune 24, 2025 | fool.comViking Therapeutics (NASDAQ:VKTX) Shares Down 5.8% - Here's WhyJune 23, 2025 | marketbeat.com2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street AnalystsJune 21, 2025 | fool.comViking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should KnowJune 20, 2025 | msn.comInstitute for Wealth Management LLC. Purchases 9,735 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)June 19, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by GAMMA Investing LLCJune 19, 2025 | marketbeat.comMN Wealth Advisors LLC Has $450,000 Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)June 18, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by Handelsbanken Fonder ABJune 16, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 5.7% - Should You Sell?June 13, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Holdings Lifted by Compagnie Lombard Odier SCmAJune 13, 2025 | marketbeat.comViking Therapeutics (VKTX) Rises on Expected DevelopmentsJune 12, 2025 | insidermonkey.comWe're Hopeful That Viking Therapeutics (NASDAQ:VKTX) Will Use Its Cash WiselyJune 12, 2025 | finance.yahoo.comHarbor Capital Advisors Inc. Sells 14,094 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)June 12, 2025 | marketbeat.comAnalysts Issue Forecasts for VKTX FY2026 EarningsJune 11, 2025 | marketbeat.comWesbanco Bank Inc. Purchases 12,000 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)June 11, 2025 | marketbeat.comViking Therapeutics Target of Unusually Large Options Trading (NASDAQ:VKTX)June 10, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 7.1% - Still a Buy?June 10, 2025 | marketbeat.comWas Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?June 9, 2025 | msn.com1 Stock Down 34% This Year to Buy and HoldJune 8, 2025 | fool.com39,652 Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX) Bought by RFG Advisory LLCJune 6, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Given Consensus Rating of "Buy" by AnalystsJune 6, 2025 | marketbeat.com Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VKTX Media Mentions By Week VKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.920.99▲Average Medical News Sentiment VKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼1116▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Madrigal Pharmaceuticals News Today Eli Lilly and Company News Today Moderna News Today Regencell Bioscience News Today Viatris News Today Ascendis Pharma A/S News Today QIAGEN News Today Blueprint Medicines News Today BridgeBio Pharma News Today Verona Pharma PLC American Depositary Share News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VKTX Stock Alerts